Literature DB >> 19205749

Membranoproliferative glomerulonephritis associated with a mutation in Wilms' tumour suppressor gene 1.

Detlef Bockenhauer1, William van't Hoff, Gil Chernin, Saskia F Heeringa, Neil J Sebire.   

Abstract

Wilms' tumour suppressor gene 1 (WT1) encodes a transcription factor required for normal development of the genitourinary system. In the kidney, mutations in WT1 can cause diffuse mesangial sclerosis or focal segmental glomerulosclerosis. Here, we report on a girl with a mutation in WT1, who developed membranoproliferative glomerulonephritis (MPGN) 3 years after completion of treatment for Wilms' tumour. This finding extends the spectrum of glomerular disease seen with WT1 mutations and could have implications for the screening of children with MPGN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205749     DOI: 10.1007/s00467-009-1135-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Two children with kidney disease. Demonstrated at the Royal College of Physicians of London.

Authors: 
Journal:  Br Med J       Date:  1978-09-23

2.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1985. A 13-year-old boy with aniridia and proteinuria 11 years after nephrectomy for a Wilms' tumor.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

Review 4.  Neoplasia and glomerular injury.

Authors:  C E Alpers; R S Cotran
Journal:  Kidney Int       Date:  1986-10       Impact factor: 10.612

5.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

Authors:  K M Call; T Glaser; C Y Ito; A J Buckler; J Pelletier; D A Haber; E A Rose; A Kral; H Yeger; W H Lewis
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

Review 6.  The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis.

Authors:  K Pritchard-Jones
Journal:  Pediatr Nephrol       Date:  1999-09       Impact factor: 3.714

7.  Wilms' tumor and glomerular disease. Occurrence with features of membranoproliferative glomerulonephritis and secondary focal, segmental glomerulosclerosis.

Authors:  P Thorner; M McGraw; S Weitzman; J W Balfe; M Klein; R Baumal
Journal:  Arch Pathol Lab Med       Date:  1984-02       Impact factor: 5.534

8.  Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group.

Authors:  Norman E Breslow; Robin Norris; Patricia A Norkool; Tammy Kang; J Bruce Beckwith; Elizabeth J Perlman; Michael L Ritchey; Daniel M Green; Kim E Nichols
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

Review 9.  The role of the Wilms' tumour-suppressor protein WT1 in apoptosis.

Authors:  Jörg Hartkamp; Stefan G E Roberts
Journal:  Biochem Soc Trans       Date:  2008-08       Impact factor: 5.407

10.  Glomerulonephritis associated with male pseudohermaphroditism and nephroblastoma.

Authors:  F E McCoy; W A Franklin; A J Aronson; B H Spargo
Journal:  Am J Surg Pathol       Date:  1983-06       Impact factor: 6.394

View more
  5 in total

1.  Recurrence of membranoproliferative glomerulonephritis after renal transplantation in Denys-Drash.

Authors:  Thomas J Neuhaus; Walter Arnold; Ariana Gaspert; Helmut Hopfer; Andreas Fischer
Journal:  Pediatr Nephrol       Date:  2010-10-28       Impact factor: 3.714

2.  Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

Authors:  Gil Chernin; Virginia Vega-Warner; Dominik S Schoeb; Saskia F Heeringa; Bugsu Ovunc; Pawaree Saisawat; Roxana Cleper; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 3.  The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations.

Authors:  Constantinos J Stefanidis; Uwe Querfeld
Journal:  Eur J Pediatr       Date:  2011-02-08       Impact factor: 3.183

4.  Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.

Authors:  Jutta Gellermann; Constantinos J Stefanidis; Andromachi Mitsioni; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2010-02-27       Impact factor: 3.714

5.  Immune-complex glomerulonephritis with a membranoproliferative pattern in Frasier syndrome: a case report and review of the literature.

Authors:  Daisuke Matsuoka; Shunsuke Noda; Motoko Kamiya; Yoshihiko Hidaka; Hisashi Shimojo; Yasushi Yamada; Tsutomu Miyamoto; Kandai Nozu; Kazumoto Iijima; Hiroyasu Tsukaguchi
Journal:  BMC Nephrol       Date:  2020-08-24       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.